Institute for Human Genetics, University of California, San Francisco 94143-0794, CA, USA.
Genomics. 2011 Aug;98(2):79-89. doi: 10.1016/j.ygeno.2011.04.005. Epub 2011 Apr 30.
The success of genome-wide association studies has paralleled the development of efficient genotyping technologies. We describe the development of a next-generation microarray based on the new highly-efficient Affymetrix Axiom genotyping technology that we are using to genotype individuals of European ancestry from the Kaiser Permanente Research Program on Genes, Environment and Health (RPGEH). The array contains 674,517 SNPs, and provides excellent genome-wide as well as gene-based and candidate-SNP coverage. Coverage was calculated using an approach based on imputation and cross validation. Preliminary results for the first 80,301 saliva-derived DNA samples from the RPGEH demonstrate very high quality genotypes, with sample success rates above 94% and over 98% of successful samples having SNP call rates exceeding 98%. At steady state, we have produced 462 million genotypes per week for each Axiom system. The new array provides a valuable addition to the repertoire of tools for large scale genome-wide association studies.
全基因组关联研究的成功与高效基因分型技术的发展是并行的。我们描述了一种基于新型高效 Affymetrix Axiom 基因分型技术的下一代微阵列的开发,我们正在使用该技术对 Kaiser Permanente 基因、环境与健康研究计划 (RPGEH) 的欧洲血统个体进行基因分型。该阵列包含 674,517 个 SNP,提供了极好的全基因组以及基于基因和候选 SNP 的覆盖度。覆盖度是使用基于 imputation 和 cross validation 的方法计算的。来自 RPGEH 的前 80,301 个唾液衍生 DNA 样本的初步结果表明,基因型质量非常高,样本成功率超过 94%,超过 98%的成功样本的 SNP 调用率超过 98%。在稳定状态下,我们为每个 Axiom 系统每周生成 4.62 亿个基因型。新的阵列为大规模全基因组关联研究的工具库提供了有价值的补充。